Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.6 USD | +3.82% | -0.80% | -37.33% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.33% | 789M | |
-2.20% | 103B | |
+6.87% | 101B | |
+4.19% | 23.07B | |
-12.31% | 22.23B | |
-4.83% | 18.05B | |
-39.98% | 17.18B | |
-11.35% | 16.94B | |
+5.97% | 14.07B | |
+37.14% | 12.35B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Deutsche Bank Adjust Sage Therapeutics Price Target to $18 From $21, Maintains Hold Rating